Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 2Prostatic Neoplasms 2Vaginal Neoplasms 1Sarcoma, Ewing 1Carcinosarcoma 1Breast Neoplasms 1Biochemically Recurrent Prostate Carcinoma 1

Interventions

Radiotherapy 2Brachytherapy 2entinostat 1bintrafusp alfa protein, human 1Vaccines 1Surveys and Questionnaires 1Radiotherapy, Intensity-Modulated 1Radiation 1Platinum 1Papillomavirus Vaccines 1Magnetic Resonance Spectroscopy 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Congresses as Topic 1Cisplatin 13-aminopyridine-2-carboxaldehyde thiosemicarbazone 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Vaginal Neoplasms × Congresses as Topic × Clear all
NCT02466971 2026-05-29

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

National Cancer Institute (NCI)

Phase 3 Active not recruiting
450 enrolled 11 charts
Gynecologic

Uterine Cervical Neoplasms, Vaginal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡